Cargando…

Strategies for Mitigating Commercial Sensor Chip Variability with Experimental Design Controls

Surface plasmon resonance (SPR) is a popular real-time technique for the measurement of binding affinity and kinetics, and bench-top instruments combine affordability and ease of use with other benefits of the technique. Biomolecular ligands labeled with the 6xHis tag can be immobilized onto sensing...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanson, Eliza K., Wang, Chien-Wei, Minkoff, Lisa, Whelan, Rebecca J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422579/
https://www.ncbi.nlm.nih.gov/pubmed/37571487
http://dx.doi.org/10.3390/s23156703
_version_ 1785089245545758720
author Hanson, Eliza K.
Wang, Chien-Wei
Minkoff, Lisa
Whelan, Rebecca J.
author_facet Hanson, Eliza K.
Wang, Chien-Wei
Minkoff, Lisa
Whelan, Rebecca J.
author_sort Hanson, Eliza K.
collection PubMed
description Surface plasmon resonance (SPR) is a popular real-time technique for the measurement of binding affinity and kinetics, and bench-top instruments combine affordability and ease of use with other benefits of the technique. Biomolecular ligands labeled with the 6xHis tag can be immobilized onto sensing surfaces presenting the Ni(2+)-nitrilotriacetic acid (NTA) functional group. While Ni-NTA immobilization offers many advantages, including the ability to regenerate and reuse the sensors, its use can lead to signal variability between experimental replicates. We report here a study of factors contributing to this variability using the Nicoya OpenSPR as a model system and suggest ways to control for those factors, increasing the reproducibility and rigor of the data. Our model ligand/analyte pairs were two ovarian cancer biomarker proteins (MUC16 and HE4) and their corresponding monoclonal antibodies. We observed a broad range of non-specific binding across multiple NTA chips. Experiments run on the same chips had more consistent results in ligand immobilization and analyte binding than experiments run on different chips. Further assessment showed that different chips demonstrated different maximum immobilizations for the same concentration of injected protein. We also show a variety of relationships between ligand immobilization level and analyte response, which we attribute to steric crowding at high ligand concentrations. Using this calibration to inform experimental design, researchers can choose protein concentrations for immobilization corresponding to the linear range of analyte response. We are the first to demonstrate calibration and normalization as a strategy to increase reproducibility and data quality of these chips. Our study assesses a variety of factors affecting chip variability, addressing a gap in knowledge about commercially available sensor chips. Controlling for these factors in the process of experimental design will minimize variability in analyte signal when using these important sensing platforms.
format Online
Article
Text
id pubmed-10422579
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104225792023-08-13 Strategies for Mitigating Commercial Sensor Chip Variability with Experimental Design Controls Hanson, Eliza K. Wang, Chien-Wei Minkoff, Lisa Whelan, Rebecca J. Sensors (Basel) Article Surface plasmon resonance (SPR) is a popular real-time technique for the measurement of binding affinity and kinetics, and bench-top instruments combine affordability and ease of use with other benefits of the technique. Biomolecular ligands labeled with the 6xHis tag can be immobilized onto sensing surfaces presenting the Ni(2+)-nitrilotriacetic acid (NTA) functional group. While Ni-NTA immobilization offers many advantages, including the ability to regenerate and reuse the sensors, its use can lead to signal variability between experimental replicates. We report here a study of factors contributing to this variability using the Nicoya OpenSPR as a model system and suggest ways to control for those factors, increasing the reproducibility and rigor of the data. Our model ligand/analyte pairs were two ovarian cancer biomarker proteins (MUC16 and HE4) and their corresponding monoclonal antibodies. We observed a broad range of non-specific binding across multiple NTA chips. Experiments run on the same chips had more consistent results in ligand immobilization and analyte binding than experiments run on different chips. Further assessment showed that different chips demonstrated different maximum immobilizations for the same concentration of injected protein. We also show a variety of relationships between ligand immobilization level and analyte response, which we attribute to steric crowding at high ligand concentrations. Using this calibration to inform experimental design, researchers can choose protein concentrations for immobilization corresponding to the linear range of analyte response. We are the first to demonstrate calibration and normalization as a strategy to increase reproducibility and data quality of these chips. Our study assesses a variety of factors affecting chip variability, addressing a gap in knowledge about commercially available sensor chips. Controlling for these factors in the process of experimental design will minimize variability in analyte signal when using these important sensing platforms. MDPI 2023-07-26 /pmc/articles/PMC10422579/ /pubmed/37571487 http://dx.doi.org/10.3390/s23156703 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hanson, Eliza K.
Wang, Chien-Wei
Minkoff, Lisa
Whelan, Rebecca J.
Strategies for Mitigating Commercial Sensor Chip Variability with Experimental Design Controls
title Strategies for Mitigating Commercial Sensor Chip Variability with Experimental Design Controls
title_full Strategies for Mitigating Commercial Sensor Chip Variability with Experimental Design Controls
title_fullStr Strategies for Mitigating Commercial Sensor Chip Variability with Experimental Design Controls
title_full_unstemmed Strategies for Mitigating Commercial Sensor Chip Variability with Experimental Design Controls
title_short Strategies for Mitigating Commercial Sensor Chip Variability with Experimental Design Controls
title_sort strategies for mitigating commercial sensor chip variability with experimental design controls
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422579/
https://www.ncbi.nlm.nih.gov/pubmed/37571487
http://dx.doi.org/10.3390/s23156703
work_keys_str_mv AT hansonelizak strategiesformitigatingcommercialsensorchipvariabilitywithexperimentaldesigncontrols
AT wangchienwei strategiesformitigatingcommercialsensorchipvariabilitywithexperimentaldesigncontrols
AT minkofflisa strategiesformitigatingcommercialsensorchipvariabilitywithexperimentaldesigncontrols
AT whelanrebeccaj strategiesformitigatingcommercialsensorchipvariabilitywithexperimentaldesigncontrols